bpc-157 human clinical trials status fda warning Approval 2026: bpc-157 fda warning news FDA
Description
Abstract Introduction Peptides occupy a strategic position between small molecules and biologics, offering high target specificity, favourable safety profiles, and chemical tractability
F.HouY.PalikarasK.AdriaanseB
JCI Insight 1:e86907
Limitations of current knowledge: The majority of mechanistic and efficacy data derive from in vitro studies and animal models
Special Populations: Adjustments by Age, Gender, and Weight Standard peptide doses work for most adults between 130 and 230 lbs (59-104 kg) aged 25 to 50
however, it is not widely available and requires validation in patients with hepatic, renal, and hematological comorbidities
